How Do Younger People Fare With Stool Tests for CRC Screening? Retrospective study answers questions raised in shift to screening at age 45 Oct 21, 2024
Novel Targeted Drug Approved for Stomach Cancers Zolbetuximab indicated alongside fluoropyrimidine- and platinum-containing chemotherapy Oct 18, 2024
Diet and Prostate Cancer; TTFields OK'd for NSCLC; Cancer Studies Retracted -- News, features, and commentary about cancer-related issues Oct 18, 2024
Drugmaker Pulls Trodelvy's Bladder Cancer Approval In confirmatory trial, antibody-drug conjugate failed to improve OS versus chemotherapy Oct 18, 2024
Pop Star Falls to His Death; Trump the 'Father of IVF'? Columbia Doc's Retractions Health news and commentary gathered by 鶹ý staff Oct 17, 2024
Radioligand Shows Promise in Metastatic Hormone-Sensitive Prostate Cancer Odds of undetectable PSA at 48 weeks doubled with addition of Pluvicto Oct 16, 2024
Nivolumab Regimen Achieves Durable PFS in Advanced Hodgkin's Lymphoma May become "treatment of choice" over brentuximab vedotin for all disease stages Oct 16, 2024
Distant Recurrence Risk in Early Breast Cancer on the Decline Trials now enroll lower-risk women who get better treatment, analysis suggests Oct 15, 2024
'Personalized' Approach to RT for Bladder Cancer Promising but Challenging Low rates of toxicity and salvage cystectomy, with 2-year survival similar to surgery Oct 13, 2024
Marstacimab Gets FDA Nod for Hemophilia A or B Without Inhibitors First once-weekly subcutaneous prophylactic option for hemophilia B Oct 11, 2024
ACS Guidelines Expand Lung Cancer Screening Eligibility -- Is That a Good Thing? Debate highlights pros and cons of the new recommendation Oct 11, 2024
Study Details Perinatal Risks of Blood Cancers Diagnosed in Pregnancy Likelihood of severe maternal morbidity more than 20 times higher versus the general population Oct 11, 2024
Kate Middleton's Post-Chemo Debut; CDC Probes Cancer Cluster; 15M Adults Have ADHD Health news and commentary gathered by 鶹ý staff Oct 11, 2024
PI3K Inhibitor Wins FDA Approval for Advanced Breast Cancer Adding inavolisib to palbociclib/fulvestrant more than doubled PFS in endocrine-resistant disease Oct 10, 2024
Frontline EGFR/VEGF Inhibition Slows Advanced EGFR-Positive Lung Cancer Osimertinib plus ramucirumab in first line shows 9-month PFS advantage over EGFR inhibition alone Oct 10, 2024
Let's Talk Breast Density; Cancer, Movies, and Music; Treatment-Induced Aging? News, features, and commentary about cancer-related issues Oct 10, 2024
Gene Therapy for Rare Brain Disease Effective, but Comes With Blood Cancer Risk 10% of patients in trials leading to eli-cel's approval developed MDS or AML Oct 09, 2024
Some Cancers Occur More Frequently in Multiple Sclerosis Patients Bladder, brain, and cervical cancer risks were higher in people with MS Oct 09, 2024
Risk of a Second Primary Melanoma Similar Regardless of Race/Ethnicity Differences in absolute, relative risk highlight complexities of analyzing rare events Oct 09, 2024
'The Office' Star Has Cancer; Trump Sent COVID Tests to Putin? 3% of Teens Are Trans Health news and commentary gathered by 鶹ý staff Oct 09, 2024
Selective Role for Single-Agent Ipilimumab After Anti-PD-1 Failure in Melanoma Two-year survival in second line for patients with BRAF/NRAS wild-type tumors Oct 08, 2024
Checkpoint Inhibitors for Lung Cancer Linked to Pulmonary Embolism Study raises questions about how to assess patient risk, experts say Oct 08, 2024
Hormonal Contraception Linked to Increased Breast Cancer Risk in BRCA1 Carriers Higher risk for ever use, increasing duration of use but no increase in BRCA2 carriers Oct 07, 2024
Real World CAR T-Cell Therapy Outcomes 'Favorable' in Relapsed/Refractory Myeloma High overall response rate, even though many were ineligible for trial leading to drug's approval Oct 04, 2024
EBV Screening Tied to Lower Nasopharyngeal Cancer Mortality Risk Substantial drops in cancer-specific mortality affirmed in Chinese trial Oct 04, 2024
Good News for CAR-T Therapy; Liquid Biopsy Progress; Anti-Psychotic for Brain Cancer News, features, and commentary about cancer-related issues Oct 04, 2024
Colorectal Cancer Screening Uptake Tripled in 45-49 Age Group Rates rose after USPSTF recommendation, but increase was uneven Oct 03, 2024
What Skin Says About Health Knowing what to look for can mean the difference between life and death Oct 03, 2024
Where Are Trump's Medical Records? New Sunscreen Under Review; Why Condoms Are Nixed Health news and commentary gathered by 鶹ý staff Oct 03, 2024
'Significant Milestone' for Radionuclide Therapy in Refractory Meningioma Small study suggests large benefit for Lu-177 dotatate in intracranial disease Oct 02, 2024
Can HPV Self-Tests Truly Replace Pap Smears? Many patients may prefer a self-collected swab over a speculum Oct 02, 2024
Chemoradiation Plus Immunotherapy Fails to Improve Survival in Limited-Stage SCLC Latest negative results emphasize "critical" aspect of immunotherapy timing Oct 02, 2024
De-Intensified Therapy Misses Mark in HPV-Positive Oropharyngeal Cancer With 98% PFS at 2 years, standard RT plus cisplatin sets a higher bar for de-escalation Oct 02, 2024
Trump Vows to Veto Abortion Ban; Breast Cancer Climbs; Diagnostic Errors for 1 in 14 Health news and commentary gathered by 鶹ý staff Oct 02, 2024
More Evidence Favors a Shorter Course of Post-Mastectomy RT Trial finds similar complication and recurrence rates with hypofractionated versus standard RT Oct 01, 2024
No Improvement in Lymphedema With Hypofractionated Nodal RT for Breast Cancer Numerical advantage in randomized trial, non-randomized study misses noninferiority mark Oct 01, 2024
VP Nominee Medical Records Breached; Queen Elizabeth's Cancer; Galaxy Gas Whippets Health news and commentary gathered by 鶹ý staff Oct 01, 2024
Quality of Life Similar With Proton Beam Therapy vs IMRT for Prostate Cancer "It really shows us that we have two great options," expert says Sep 30, 2024
H. Pylori Testing Did Not Reduce Gastric Cancer Incidence, Mortality Gastric cancer incidence was lower after adjusting for certain factors in post hoc analyses Sep 30, 2024
